Get Real Time Here
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Day Range8.871 - 9.220 | 52 Wk Range4.070 - 20.475 | Open / Close9.100 / - | Float / Outstanding141.687M / 142.110M |
| Vol / Avg.1.377M / 3.117M | Mkt Cap1.303B | P/E- | 50d Avg. Price6.080 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.060 | 0.1100 | ||||
| REV | 36.180M | 55.779M | 19.599M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals's (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the target price for Aurinia Pharmaceuticals (AUPH) stock?
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.